Insiders · Profile

Riley Jeffrey Scott

Director at Gain Therapeutics · CEO and President at Theriva Biologics. Filing since 2 Jan 2013. CIK 0001487645

Company
Date
Role
Action
Shares
Amount
Of holding
28 Mar 2024
Director
Bought
30,000
$115.77K
opened
7 Jan 2013
CEO and President
Bought
2,900
$506.49
38.7%
3 Jan 2013
CEO and President
Bought
4,800
$8.32K
178%
2 Jan 2013
CEO and President
Bought
2,700
$4.81K
opened
4 decisions on file.